News

Novo Nordisk slashed its financial forecasts as it struggled to fight off competition in the United States. It also named a ...
The overarching commonality is that there isn't one: "Not all people experiences the same degree of facial and body changes ...
Novo Nordisk’s plummet is a warning for backers who’ve crowded into a relatively small group of very large stocks.
While Ozempic is effective at treating type 2 diabetes and supporting weight loss, it can also come with side effects.
Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...
Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...
Peanuts instead of Panadol and a salad that can kill your appetite could be the results of a new Sydney research project.
Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) is watching its stock plummet 20% in morning trading after slashing its ...
Shares in Novo Nordisk fell as much as 30% after it slashed sales and profits forecasts for the second time this year amid ...
A growing number of people are turning to medications like Ozempic, Wegovy, and Mounjaro to aid in weight loss and manage ...
The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.